About Stephen Sofen
Form D filings for Abata Therapeutics from 2022 to 2023 list Stephen Sofen as executive officer.
Stephen Sofen first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Stephen Sofen in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Stephen Sofen works with at each company, as listed on that company's latest Form D.
Abata Therapeutics, Inc. · Form D, Dec 27, 2023
SS
Samantha Singer
Chief Executive Officer and director
LD
Leonard Dragone
Executive officer
VO
Valerie Odegard
Director
SL
Sandy Lazzari
Executive officer
SC
Shelley Chu
Director
NM
Nagesh Mahanthappa
Director
JT
John Trzupek
Executive officer
AC
Abbie Celniker
Director
MF
Mitch Finer
Director
DK
David Kaufman
Director
LK
Lorence Kim
Director
EM
Ellen Cahir-Mcfarland
Executive officer